BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10753933)

  • 1. The dominant negative LQT2 mutation A561V reduces wild-type HERG expression.
    Kagan A; Yu Z; Fishman GI; McDonald TV
    J Biol Chem; 2000 Apr; 275(15):11241-8. PubMed ID: 10753933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retention in the endoplasmic reticulum as a mechanism of dominant-negative current suppression in human long QT syndrome.
    Ficker E; Dennis AT; Obejero-Paz CA; Castaldo P; Taglialatela M; Brown AM
    J Mol Cell Cardiol; 2000 Dec; 32(12):2327-37. PubMed ID: 11113008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the cyclic nucleotide binding domain of the HERG potassium channel and interactions with KCNE2.
    Cui J; Kagan A; Qin D; Mathew J; Melman YF; McDonald TV
    J Biol Chem; 2001 May; 276(20):17244-51. PubMed ID: 11278781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction of defective protein trafficking of a mutant HERG potassium channel in human long QT syndrome. Pharmacological and temperature effects.
    Zhou Z; Gong Q; January CT
    J Biol Chem; 1999 Oct; 274(44):31123-6. PubMed ID: 10531299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutations.
    Ficker E; Obejero-Paz CA; Zhao S; Brown AM
    J Biol Chem; 2002 Feb; 277(7):4989-98. PubMed ID: 11741928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mechanism associated with an inherited cardiac arrhythmia: defective protein trafficking by the mutant HERG (G601S) potassium channel.
    Furutani M; Trudeau MC; Hagiwara N; Seki A; Gong Q; Zhou Z; Imamura S; Nagashima H; Kasanuki H; Takao A; Momma K; January CT; Robertson GA; Matsuoka R
    Circulation; 1999 May; 99(17):2290-4. PubMed ID: 10226095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction with GM130 during HERG ion channel trafficking. Disruption by type 2 congenital long QT syndrome mutations. Human Ether-à-go-go-Related Gene.
    Roti EC; Myers CD; Ayers RA; Boatman DE; Delfosse SA; Chan EK; Ackerman MJ; January CT; Robertson GA
    J Biol Chem; 2002 Dec; 277(49):47779-85. PubMed ID: 12270925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and functional characterization of a novel KCNE2 (MiRP1) mutation that alters HERG channel kinetics.
    Isbrandt D; Friederich P; Solth A; Haverkamp W; Ebneth A; Borggrefe M; Funke H; Sauter K; Breithardt G; Pongs O; Schulze-Bahr E
    J Mol Med (Berl); 2002 Aug; 80(8):524-32. PubMed ID: 12185453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a novel missense mutation in the pore of HERG in a patient with long QT syndrome.
    Yoshida H; Horie M; Otani H; Takano M; Tsuji K; Kubota T; Fukunami M; Sasayama S
    J Cardiovasc Electrophysiol; 1999 Sep; 10(9):1262-70. PubMed ID: 10517660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-QT syndrome-associated missense mutations in the pore helix of the HERG potassium channel.
    Huang FD; Chen J; Lin M; Keating MT; Sanguinetti MC
    Circulation; 2001 Aug; 104(9):1071-5. PubMed ID: 11524404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thapsigargin selectively rescues the trafficking defective LQT2 channels G601S and F805C.
    Delisle BP; Anderson CL; Balijepalli RC; Anson BD; Kamp TJ; January CT
    J Biol Chem; 2003 Sep; 278(37):35749-54. PubMed ID: 12837749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of S818L mutation in HERG C-terminus in LQT2. Modification of activation-deactivation gating properties.
    Nakajima T; Kurabayashi M; Ohyama Y; Kaneko Y; Furukawa T; Itoh T; Taniguchi Y; Tanaka T; Nakamura Y; Hiraoka M; Nagai R
    FEBS Lett; 2000 Sep; 481(2):197-203. PubMed ID: 10996323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunction of delayed rectifier potassium channels in an inherited cardiac arrhythmia.
    Sanguinetti MC
    Ann N Y Acad Sci; 1999 Apr; 868():406-13. PubMed ID: 10414310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective human Ether-à-go-go-related gene trafficking linked to an endoplasmic reticulum retention signal in the C terminus.
    Kupershmidt S; Yang T; Chanthaphaychith S; Wang Z; Towbin JA; Roden DM
    J Biol Chem; 2002 Jul; 277(30):27442-8. PubMed ID: 12021266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mutation (T65P) in the PAS domain of the human potassium channel HERG results in the long QT syndrome by trafficking deficiency.
    Paulussen A; Raes A; Matthijs G; Snyders DJ; Cohen N; Aerssens J
    J Biol Chem; 2002 Dec; 277(50):48610-6. PubMed ID: 12354768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mechanism of HERG current suppression in LQT2: shift in voltage dependence of HERG inactivation.
    Nakajima T; Furukawa T; Tanaka T; Katayama Y; Nagai R; Nakamura Y; Hiraoka M
    Circ Res; 1998 Aug; 83(4):415-22. PubMed ID: 9721698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human delta1261 mutation of the HERG potassium channel results in a truncated protein that contains a subunit interaction domain and decreases the channel expression.
    Li X; Xu J; Li M
    J Biol Chem; 1997 Jan; 272(2):705-8. PubMed ID: 8995352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long QT syndrome: cellular basis and arrhythmia mechanism in LQT2.
    January CT; Gong Q; Zhou Z
    J Cardiovasc Electrophysiol; 2000 Dec; 11(12):1413-8. PubMed ID: 11196567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cardiac delayed rectifier K+ current by overexpression of the long-QT syndrome HERG G628S mutation in transgenic mice.
    Babij P; Askew GR; Nieuwenhuijsen B; Su CM; Bridal TR; Jow B; Argentieri TM; Kulik J; DeGennaro LJ; Spinelli W; Colatsky TJ
    Circ Res; 1998 Sep; 83(6):668-78. PubMed ID: 9742063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voltage-shift of the current activation in HERG S4 mutation (R534C) in LQT2.
    Nakajima T; Furukawa T; Hirano Y; Tanaka T; Sakurada H; Takahashi T; Nagai R; Itoh T; Katayama Y; Nakamura Y; Hiraoka M
    Cardiovasc Res; 1999 Nov; 44(2):283-93. PubMed ID: 10690305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.